Belite Bio, Inc (BLTE) Receivables - Other (2022 - 2025)
Belite Bio (BLTE) posted quarterly Receivables - Other of $700000.0 for Q4 2025, up 21.74% year-over-year from $575000.0 in Q4 2024, and up 11566.67% on a QoQ basis from $6000.0 in Q3 2025.
Belite Bio, Inc (BLTE) Receivables - Other (2022 - 2025) Analysis & Trends
Belite Bio (BLTE) has reported Receivables - Other for 4 consecutive years, with $700000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other rose 21.74% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (up 21.74% YoY), while the FY2025 annual figure was $700000.0, up 21.74% from the prior year.
- Receivables - Other came in at $700000.0 for Q4 2025 at Belite Bio, up from $6000.0 in the prior quarter.
- The five-year high for Receivables - Other was $818000.0 in Q4 2023, with the low at $2000.0 in Q4 2022.
- Average Receivables - Other over 4 years is $353166.7, with a median of $296500.0 recorded in 2024.
- Across the five-year window, Receivables - Other surged 40800.0% in 2023 and tumbled 66.67% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $2000.0 in 2022, then soared by 40800.0% to $818000.0 in 2023, then decreased by 29.71% to $575000.0 in 2024, then increased by 21.74% to $700000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $700000.0, $6000.0, and $575000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |